Gurnet Point Capital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Macrolide PharmaceuticalsinApr 2018 · $20M
BiotechWatertown, US
Edward Mascioli(Executive Officer)Andrew Myers(Director)
BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)Raj Parekh(Director)in
Co-investorsAdvent Life SciencesNovartis Venture FundRoche Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

